Answering real-world clinical questions using large language model, retrieval-augmented generation, and agentic systems

By sjmartinez • June 13, 2025

Low YS, Jackson ML, Hyde RJ, Brown RE, Sanghavi NM, Baldwin JD, Pike CW, Muralidharan J, Hui G, Alexander N, Hassan H, Nene RV, Pike M, Pokrzywa CJ, Vedak S, Yan AP, Yao DH, Zipursky AR, Dinh C, Ballentine P, Derieg DC, Polony V, Chawdry RN, Davies J, Hyde BB, Shah NH, Gombar S. Answering real-world clinical questions using large language model, retrieval-augmented generation, and agentic systems. Digit Health. 2025 Jun 9;11:20552076251348850. doi: 10.1177/20552076251348850. PMID: 40510193; PMCID: PMC12159471.

Tags: Artificial intelligence, Cohort study, evidence-based medicine, Fellow, Hematology/Oncology, Large language models, Publications, retrieval-augmented generation

Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed NPM1-Mutated or KMT2A-Rearranged AML

Zeidner JF, Lin TL, Welkie RL, Curran E, Koenig K, Stock W, Madanat YF, Swords R, Baer MR, Blum W, Stein EM, Olin RL, Schiller[...]

Anti-HIV-1 HSPC-based gene therapy with safety kill switch to defend against and attack HIV-1 infection

Guo Q, Parikh K, Zhang J, Brinkley A, Chen G, Jakramonpreeya N, Zhen A, An DS. Anti-HIV-1 HSPC-based gene therapy with safety kill switch to[...]

Mirvetuximab soravtansine for the treatment of epithelial ovarian, fallopian tube, or primary peritoneal cancer

Silverstein J, Smick A, Johnson B, Konecny GE. Mirvetuximab soravtansine for the treatment of epithelial ovarian, fallopian tube, or primary peritoneal cancer. Future Oncol. 2025[...]